The Role of Biomarkers in Cardiovascular Diseases

Dear Colleagues,

As is well known, cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide, underscoring the urgent need for innovative diagnostic and therapeutic strategies. Biomarkers have emerged as critical elements in addressing these challenges, offering valuable insights into disease mechanisms, risk stratification, and treatment response. The advent of omics technologies has further facilitated the identification of thousands of potential biomarkers, significantly expanding the opportunities for improving early detection and predicting outcomes across a broad range of CVDs. However, despite this promise, the journey from biomarker discovery to clinical application is often full of challenges that impede validation and implementation.

The scope of this Special Issue, "The Role of Biomarkers in Cardiovascular Diseases”, is to explore the multifaceted role of both traditional and non-traditional biomarkers in enhancing our understanding of CVDs, improving early detection, and guiding personalized treatment approaches.

We invite researchers and clinicians to submit original research and comprehensive reviews focused on novel and established cardiovascular biomarkers, their pathophysiological relevance, and their use in precision medicine for cardiovascular care. Your contributions are essential to bridge the gap between research and clinical applications, ultimately improving patient outcomes.

Thank you for your participation, and we look forward to your submissions!

Dr. Giorgia Panichella
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.